We are live on
!
Find out more
FRM
Fox Run Management Portfolio holdings
AUM
$572M
1-Year Est. Return
24.16%
This Fund
S&P 500
This Quarter
Est. Return
+2.63%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$289M
AUM Growth
+$44.1M
(+18%)
Cap. Flow
+$42.9M
Cap. Flow
% of AUM
14.81%
Top 10 Holdings %
Top 10 Hldgs %
5.2%
Holding
950
New
406
Increased
107
Reduced
92
Closed
345
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Azenta
AZTA
|
+$1.66M |
| 2 |
ConocoPhillips
COP
|
+$1.5M |
| 3 |
United Airlines
UAL
|
+$1.46M |
| 4 |
MSCI
MSCI
|
+$1.46M |
| 5 |
SAVE
Spirit Airlines, Inc.
SAVE
|
+$1.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$1.39M |
| 2 |
Comcast
CMCSA
|
+$1.29M |
| 3 |
Walt Disney
DIS
|
+$1.27M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.24M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.46% |
| 2 | Consumer Discretionary | 13.76% |
| 3 | Technology | 13.34% |
| 4 | Industrials | 12.71% |
| 5 | Healthcare | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLCM
376
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $328K | 0.11% |
2,810
+1,427
| +103% | +$177K |
|
|
SONC
377
DELISTED
Sonic Corp
SONC
| $328K | 0.11% |
+12,400
| New | +$342K |
|
378
Lear
LEA
$7.14B
| $327K | 0.11% |
2,300
-100
| -4% | -$14.2K |
|
379
Jacobs Solutions
J
$15.6B
| $326K | 0.11% |
7,254
+846
| +13% | +$37.6K |
|
380
Maximus
MMS
$3.02B
| $326K | 0.11% |
+5,200
| New | +$323K |
|
381
Kohl's
KSS
$2.06B
| $325K | 0.11% |
8,400
-9,400
| -53% | -$360K |
|
382
Paylocity
PCTY
$6.46B
| $325K | 0.11% |
+7,200
| New | +$314K |
|
|
VMW
383
DELISTED
VMware, Inc
VMW
| $323K | 0.11% |
3,700
+400
| +12% | +$36.9K |
|
384
DexCom
DXCM
$27.2B
| $322K | 0.11% |
+17,600
| New | +$325K |
|
385
Integra LifeSciences
IART
$1.44B
| $322K | 0.11% |
5,900
-22,100
| -79% | -$1.06M |
|
|
CSII
386
DELISTED
Cardiovascular Systems, Inc.
CSII
| $319K | 0.11% |
+9,900
| New | +$302K |
|
387
YPF
YPF
$20.4B
| $318K | 0.11% |
+14,500
| New | +$351K |
|
|
HZNP
388
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $316K | 0.11% |
+26,600
| New | +$331K |
|
|
MBT
389
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $316K | 0.11% |
+37,700
| New | +$363K |
|
390
Cintas
CTAS
$81.3B
| $315K | 0.11% |
+10,000
| New | +$311K |
|
391
Illinois Tool Works
ITW
$79.7B
| $315K | 0.11% |
2,200
-1,900
| -46% | -$265K |
|
392
HCA Healthcare
HCA
$83.5B
| $314K | 0.11% |
3,600
-2,468
| -41% | -$209K |
|
393
CareTrust REIT
CTRE
$10B
| $313K | 0.11% |
+16,900
| New | +$305K |
|
394
Monster Beverage
MNST
$91.5B
| $313K | 0.11% |
12,600
-32,600
| -72% | -$785K |
|
395
Becton Dickinson
BDX
$42.1B
| $312K | 0.11% |
+1,640
| New | +$300K |
|
396
Unum
UNM
$13.8B
| $312K | 0.11% |
+6,700
| New | +$308K |
|
397
Cathay General Bancorp
CATY
$4.19B
| $311K | 0.11% |
+8,200
| New | +$308K |
|
|
GNC
398
DELISTED
GNC Holdings, Inc.
GNC
| $311K | 0.11% |
+36,900
| New | +$278K |
|
|
CAA
399
DELISTED
CalAtlantic Group, Inc.
CAA
| $311K | 0.11% |
+8,800
| New | +$320K |
|
|
BBBY
400
DELISTED
Bed Bath & Beyond Inc
BBBY
| $310K | 0.11% |
+10,200
| New | +$369K |
|
Similar funds
MAM
NA
EHI
MW
BSG
RI
XI
TWA
Fox Run Management's Q2 2017 Portfolio in Review
As of Q2 2017, Fox Run Management held 950 positions worth $289M, up 18% from $245M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
Fox Run Management deployed $42.9M of net new capital in Q2 2017, opening 406 new positions and adding to 107 existing holdings. Its largest new stake was Azenta: 65,500 shares worth $1.42M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $1.16M trimmed.
- Fox Run Management's largest Q2 2017 buy was Azenta: 65,500 shares worth $1.42M.
- Fox Run Management added most to ConocoPhillips in Q2 2017, an estimated $1.5M increase.
- Fox Run Management's biggest Q2 2017 reduction was Edwards Lifesciences, cutting an estimated $1.16M.
- Fox Run Management fully exited Oracle in Q2 2017, selling an estimated $1.39M.
- Fox Run Management's ten largest holdings make up 5.2% of its $289M portfolio in Q2 2017.
- Fox Run Management opened 406 new positions and closed 345 in Q2 2017.
- Fox Run Management's portfolio value rose 18% quarter-over-quarter to $289M.
Based on Fox Run Management's 13F filing for Q2 2017, filed 10 Jul 2017.